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Alzheimer's disease, progressive supranuclear palsy and frontotemporal dementia are characterized by
neuronal expression of aberrant tau protein, tau hyperphosphorylation (pTAU), tau aggregation and
neurofibrillary tangle formation sequentially culminating into neuronal cell death, a process termed
tauopathy. Our aim was to address at which tauopathy stage neuroinflammation starts and to study the
related microglial phenotype. We used Thy1-hTau.P301S (PS) mice expressing human tau with a P301S
mutation specifically in neurons. Significant levels of cortical pTAU were present from 2 months on-
wards. Dystrophic morphological complexity of cortical microglia arose after pTAU accumulation
concomitant with increased microglial lysosomal volumes and a significant loss of homeostatic marker
Tmem119. Interestingly, we detected increases in neuronal pTAU and postsynaptic structures in the ly-
sosomes of PS microglia. Moreover, the overall cortical postsynaptic density was decreased in 6-month-
old PS mice. Together, our results indicate that microglia adopt a pTAU-associated phenotype, and are
morphologically and functionally distinct from wild-type microglia after neuronal pTAU accumulation
has initiated.
 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Intraneuronal aggregated tau inclusions, caused by tau hyper-
phosphorylation, are among the hallmarks of multiple neurode-
generative diseases such as Alzheimer's disease (AD), progressive
supranuclear palsy, and other tauopathies including fronto-
temporal lobar degeneration (FTLD-tau) and related frontotemporal
dementia (FTD) (Spillantini and Goedert, 2013). The development of
tauopathies is a multistep process ultimately leading to neurofi-
brillary tangle (NFT) formation and neurodegeneration (Lee et al.,lar Cell Biology and Immu-
De Boelelaan 1108, PO Box
Tel.: þ31204448080; fax:
n Olst).
Inc. This is an open access article u2001). Familial FTLD-tau/FTD associated with tau gene MAPT mu-
tations demonstrate that tau aberrancies alone can be sufficient to
cause neurodegeneration and dementia (Spillantini and Goedert,
2013). Similarly, mouse models expressing human tau harboring a
P301S mutation, phenocopy a number of both behavioral and
pathological properties observed in familial FTLD-tau/FTD cases
(Allen et al., 2002; Takeuchi et al., 2011; Yoshiyama et al., 2007).
Neuroinflammation is among these pathological properties
frequently reported, yet the exact timing and consequences remain
elusive (Streit et al., 2009; Yoshiyama et al., 2007). Microglia are the
brain-resident immune cells that constantly scan their environ-
ment and initiate phagocytosis of pathogens and debris using their
highly motile processes (Nimmerjahn et al., 2005; Sierra et al.,
2013). Accordingly, on brain insults, microglia actively adapt their
shape and function (Fernández-Arjona et al., 2017; Nimmerjahn
et al., 2005; Sierra et al., 2013). The response of microglia towardnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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data regarding microglial morphology during the tauopathy pro-
cess are currently lacking. Previous literature suggests that micro-
gliosis may precede NFT formation and could thus be considered an
early manifestation associated with the tau P301S mutation
(Yoshiyama et al., 2007).
Furthermore, several groups have reported microglia to be in
close contact with NFTs in AD brain tissue (Cras et al., 1991; StreitFig. 1. Spatiotemporal PHF6 and AT8 expression immunohistochemistry analysis. (A) Micro
cortical and hippocampal AT8 staining. (C) Bar graphs displaying cortical and hippocampal p
hippocampal pTAU AT8þ surface area relative to total surface. Scale bars are 250 mm in overv
indicated *p < 0.05, **p < 0.01, and ***p < 0.001, two-way ANOVA, n ¼ 3e4 per experimenet al., 2009) and, owing to the phagocytic nature of microglia,
they are thought to phagocytose neuronal content expressing
pathological tau. This idea is partially supported by in vitro and
ex vivo tau phagocytosis experiments (Brelstaff et al., 2018; Luo
et al., 2015) and findings on human isolated tau species injected
in the mouse brain (Bolós et al., 2017). However, in vivo experi-
ments on phagocytosis of endogenously expressed neuronal pTAU
in the brain are missing. Here, we describe that pTAU aggregationgraphs displaying cortical and hippocampal PHF6 staining. (B) Micrographs displaying
TAU PHF6þ surface area relative to total surface. (D) Bar graphs displaying cortical and
iew images and 20 mm in the further magnified insets (A, B). Significant differences are
tal group (C, D).
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(PS) mice. The pTAU-induced microglial phenotype observed con-
sists of morphological dystrophy, loss of homeostatic markers, and
lysosomal swelling. Interestingly, lysosomal swelling of PS micro-
glia coincided with lysosomal localization of both pTAU and post-
synaptic structures, together with an overall loss of cortical
postsynaptic spine density.
2. Results and discussion
First, pTAU expression in PS and wild-type (WT) mice was
assessed in a spatiotemporal manner using immunofluorescence of
tau protein phosphorylation at Thr231 (PHF6) (Fig. 1A) and tau
protein phosphorylation at Ser202 and Thr205 (AT8) (Fig. 1B, Figs.
S1 and S2). Both PHF6 and AT8 identify pTAU forms early in tauFig. 2. Temporal soluble and insoluble cortical AT8 expression western blot analysis. (A) Rep
(NSE) loading control staining. (B) Bar graph displaying NSE normalized cortical total hom
expression and NSE loading staining. (D) Bar graph displaying NSE normalized Tris-soluble
AT8 staining. (F) Bar graph displaying sarkosyl-insoluble cortical AT8 expression. Significant
group, two-way ANOVA.inclusion formation, with PHF6 as one of the first belonging to the
sequential cascade of phospho-epitopes to appear during pretangle
formation in AD (Luna-Muñoz et al., 2007). In the cortex of PS mice,
PHF6 and AT8 immunoreactivity increased significantly from
4 months onwards (Fig. 1), with PHF6 showing the earliest rise in
signal. The pyramidal cell layer of the hippocampal cornus
ammonum and granule cell layer of the hippocampal dentate gyrus
of PS mice showed a significant albeit milder increase in PHF6þ and
a slower increase in AT8þ signal from, respectively, 4- and 6-
months forth (Fig. 1CeD), as reported previously (Allen et al.,
2002). As the onset of cortical pTAU preceded that of the hippo-
campus, we next measured the degree of cortical pTAU aggregation
using total (Fig. 2AeB), tris-soluble (Fig. 2CeD), and sarkosyl-
insoluble (Fig. 2EeF) fractions by means of western blot analysis.
These data indicated that levels of tris-soluble AT8 in the cortexresentative blots displaying cortical total homogenate AT8 and neuron-specific enolase
ogenate AT8 expression. (C) Representative blots displaying cortical Tris-soluble AT8
cortical AT8 expression. (E) Representative blots displaying cortical sarkosyl-insoluble
differences are indicated ***p < 0.001, WT versus PS mice, n ¼ 5e10 per experimental
L. van Olst et al. / Neurobiology of Aging 89 (2020) 89e9892were robustly present from 2 months onwards and subsequently
started to aggregate from 5 months forth in PS mice.
Next, wemeasured the microglial response to pTAU aggregation
by analyzing Iba1þ cell morphology in the cortex of PS mice usingFig. 3. Age- and genotype-associated changes in morphological complexity of cortical Iba1þ
traces (bottom). (B) Sholl plots per age displaying Iba1þ cell branch intersections per 2 mm st
graph. (D) Micrographs of cortical Iba1þ cells. (E) Bar graph displaying the Iba1þ surface are
bars ¼ 20 mm (A), 500 mm overview (D) and 50 mm (D’) in the further magnified insets. Signifi
# p < 0.05 (age effect between age groups), two-way ANOVA (C, E). N ¼ 5e8 per experimeSholl analysis (Fig. 3A). Different microglial morphophenotypes,
although currently still under debate, appear to be associated with
alterations in microglial activation status (Fernández-Arjona et al.,
2019). As has been previously reported by us and others, agingcells from PS mice. (A) Micrographs of cortical Iba1þ cells (top) and their respective
eps from the cell soma. (C) Sholl-derived area under the curve (arbitrary units: A.U.) bar
a at 5.5 months. (F) Plots displaying the number of Iba1þ cells per cortical mm3. Scale
cant differences are indicated, *p < 0.05, **p < 0.01 (genotype effect within age group),
ntal group (B, C, E).
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van Olst et al., 2018) and on genes expressed by microglia cells that
are involved in cell adhesion, and actin (dis)assembly (Galatro et al.,
2017). Indeed, we found a significant age-related reduction in Iba1þ
cell complexity from 4 months onwards in the cortex of PS mice
(Fig. 3AeC). A significant genotype effect, however, emerged later at
5.5 months of age with further decreases in cortical Iba1þ
complexity (Fig. 3C). This reduced morphological complexity at 5.5
months of age coincided with a smaller area occupied by cortical
Iba1þ cells in PS compared to WT mice (Fig. 3DeE) but not by a
changed number of Iba1þ cells per area (Fig. 3F). These data indi-
cate that a PS-induced microglia phenotype, as measured by
microglia morphological complexity, arises approximately
3.5 months after the first detection of cortical PHF6 immunoreac-
tivity (Fig. 1C) and soluble AT8 levels (Fig. 2CeD), and 2 weeks after
the occurrence of insoluble AT8 aggregation (Fig. 2EeF). These
findings might be compatible with those from Yoshiyama et al.
reporting microglial activation to precede tangles in their prion-
promoteredriven human tau P301Smousemodel (Yoshiyama et al.,
2007), as NFT formation follows tau hyperphosphorylation and
aggregation. Our results combined with those reported by Yosh-
iyama et al. could imply that the timing of a microglial response to
tau aberrancies occur in the final stages of early tau processing, yet
before NFT formation (Yoshiyama et al., 2007). In the hippocampal
regions of PS mice, we observed a milder and slower tau pathologyFig. 4. Homeostatic microglia marker expression analysis of P2Y12 and Tmem119 in cortica
representative cortical Iba1þ/Tmem119þ microglia. (B) Bar graph displaying mean fluoresc
(arbitrary units: A.U.). (C) Maximum projection confocal micrograph displaying a represen
tensity P2Y12 signal from Iba1þmicroglia of 5.5-month-old WT and PS mice (arbitrary units
experimental group, Student's t-test. Scale bars ¼ 25 mm.(Fig. 1CeD) together with absence of a morphological response of
microglia (Fig. S2). This mild kinetic is in accordance with obser-
vations of less severe tauopathy pathogenesis in the limbic system
of humanpatients with FTD compared to other brain regions (Neary
et al., 2005) and with the notion that microglia in the hippocampus
are more immune vigilant (Grabert et al., 2016).
To understand whether the aforementioned cortical PS-induced
microglial phenotype could be attributed to the recently described
microglial neurodegenerative (MGnD) phenotype (Krasemann et al.,
2017) or disease-associated microglial (DAM) phenotype (Keren-
Shaul et al., 2017), we analyzed the expression of homeostatic
microglia markers P2Y12 and Tmem119 in Iba1þ cells in the cortex
at 5.5 months (Fig. 4). In accordance with a previous report
(Litvinchuk et al., 2018), our results show that corticalmicroglia of PS
mice display significantly decreased expression levels of Tmem119
(Fig. 4AeB) and a non-significant reduction in P2Y12 expression
(Fig. 4CeD). These results suggest that pTAU-induced microglial
activation might be accompanied by the MGnD/DAM phenotype.
We next analyzed microglial CD68 lysosome/endosome
expression as a further measure for microglia activation. CD68þ
volume within cortical Iba1þ cells (Fig. 5A) was mildly, yet signif-
icantly, higher in PS mice compared to WT mice at 5.5 months
(Fig. 5B). The increase in Iba1þ/CD68þ volume at 5.5 months
(Fig. 5C) could not be explained by the unchanged number of
CD68þ objects (Fig. 5D), but could be explained by the increasedl Iba1þ cells from PS mice. (A) Maximum projection confocal micrograph displaying a
ent intensity Tmem119 signal from Iba1þ microglia of 5.5-month-old WT and PS mice
tative cortical Iba1þ/P2Y12þ microglia. (D) Bar graph displaying mean fluorescent in-
: A.U.). Significant differences are indicated, ***p < 0.001, WT versus PS mice, n ¼ 6 per
Fig. 5. Age- and genotype-associated changes in CD68þ object volume and AT8þ content of cortical Iba1þ cells from PS mice. (A) Micrographs displaying cortical CD68þ signal
within cortical Iba1þ cells' mask. (B) Plots displaying the relative CD68þ volume in cortical Iba1þ cells. (C) Bar graph displaying the relative CD68þ volume in cortical Iba1þ cells at
5.5 months. (D) Bar graph displaying the number of CD68þ objects in cortical Iba1þ cells at 5.5 months. (E) Bar graph displaying the average volume of CD68þ objects in cortical
Iba1þ cells at 5.5 months. (F) Representative unmasked micrographs displaying AT8þ cell engulfment by an Iba1þ cell (top) and AT8þ signal localized in sequentially
masked Iba1þ/CD68þ signal in the cortex of a 5.5-month-old PS mouse. Boxed areas are magnified in the bottom right corner of each image. Arrowheads indicate AT8þ signal
within an Iba1þ/CD68þ masked region of interest magnified in (F’). (G) Plots displaying the relative AT8þ volume within the Iba1þ/CD68þ masked region of interest. Significant
differences from two-way ANOVA (B and H) and Student's t-test (C, D, and E) are indicated *p < 0.05, **p < 0.01, ***p < 0.001, (genotype effect within age group). Scale bars ¼ 20 mm
(A and F) and 4 mm (F’). N ¼ 5e6 per genotype.
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(Fig. 5E). These results suggest CD68þ lysosomes/endosomes to
swell in cortical microglia of PS mice at 5.5 months.
We next hypothesized the lysosomal swelling to be related to
microglial engulfment of both neuron-derived pTAU and synapses.
Indeed, next to microglial engulfment of AT8þ neuronal structures,
sequential masking of the Iba1þ, CD68þ, and AT8þ signal (Fig. 5F)
revealed increases in lysosomal/endosomal pTAU content in corticalmicroglia of PS mice reaching significance at 5.5 months (Fig. 5G).
These in vivo results suggest that microglial engulfment of pTAU
leads to lysosome-mediated degradation, and complement pre-
liminary engulfment data reported earlier from the same PS animals
(Brelstaff et al., 2018). So far, several groups have reported on the
phagocytic capacity of healthy microglia on challenge with extra-
cellular sources of pTAU (Bolos et al., 2017; Luo et al., 2015).Whether
this phagocytic capacity upholds when microglia are confronted
L. van Olst et al. / Neurobiology of Aging 89 (2020) 89e98 95with an aged and neurodegenerated brain environment should be
further investigated. Together, our data show that endogenously
expressed neuron-derived pTAU results in microglial pTAU uptake.
How microglia then process and/or are affected by pTAU uptake
remains elusive. To our knowledge, we are the first to describe
neuron-derived pTAU localization to microglial lysosomes of PS
mice in vivo.
Interestingly, engulfed tau protein by microglia cells has been
reported to enhance tau propagation throughout the brain via
exosome secretion (Asai et al., 2015). Both microglia depletion (Asai
et al., 2015) and blockade of microglia proliferation (Mancuso et al.,
2019) in the early stages of the pTAU cascadewere able to attenuateFig. 6. Genotype-associated changes in Homer1þ spine density and spine engulfment by co
expression at 6 months of Iba1 (white), DAPI (blue), Lamp1 (green), and Homer1 (red); comp
spots associated with Iba1þ Lamp1þ volumes. (B) Bar graph displaying the number of Ho
volumes) per total volume (mm3) at 6 months. (C) Bar graph displaying the relative Lamp1
ferences from Student's t-tests (B, C) are indicated *p < 0.05. N ¼ 5e9 per genotype. (For int
Web version of this article.)tau pathology and reduce neurodegeneration, whereas microglial
depletion in aged tauopathy mice appeared not to affect tau burden
(Bennett et al., 2018). In accordance with our results, this shows
that in vivo, microglia are actively involved in phagocytosis and
subsequent degradation of neuron-derived pathological tau species
in the early stages of tau processing.
Furthermore, we analyzed postsynaptic density levels of Hom-
er1þ spines in the cortex of PS mice at 6 months (Fig. 6A). We
detected a decrease in Homer1þ postsynaptic spine density in the
cortex of PS mice (Fig. 6B), which is in accordance with other
studies that described synaptic loss in models of tauopathy
(Hoffmann et al., 2013; Kopeikina et al., 2013). Recently, it wasrtical Iba1þ cells from PS mice. (A) From left to right: Micrographs displaying cortical
uted total Homer1þ spots; Homer1þ spots associated with Iba1þ volumes; Homer1þ
mer1þ spots (total; associated with Iba1þ volumes; associated with Iba1þ/Lamp1þ
þ volume in cortical Iba1þ cells at 6 months. Scale bars ¼ 10 mm (A). Significant dif-
erpretation of the references to color in this figure legend, the reader is referred to the
Table 1
Primary antibodies used
Antigen Species Dilution Manufacturer Cat. Number
CD68 Rat 1:400 Serotec FA-11
Homer1 Rabbit 1:500 Synaptic Systems 160,003
Iba1 Rabbit 1:1000 Wako 019e19,741
Iba1 Goat 1:500 Abcam ab5076
P2Y12 Rabbit 1:500 AnaSpec 55043A
pTAU (AT8) Mouse 1:500 ThermoFisher MN1020
pTAU (PHF6) Mouse 1:400 Biolegend 828901
Tmem119 Rabbit 1:200 Abcam ab209064
Key: CD68, cluster of differentiation 68; Homer1, homer protein homolog 1; Iba1,
ionized calcium-binding adapter molecule 1; pTAU, Phospho-Tau; Tmem119,
transmembrane protein 119.
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by increased engulfment of synaptic spines (Dejanovic et al., 2018).
While the number of total contacted Homer1þ spines by Iba1þ
cells was unchanged (Fig. 6B), we did detect a significant increase in
the number of Homer1þ postsynaptic structures in Lamp1þ lyso-
somes of Iba1þ cells in the cortex of PS mice (Fig. 6B). As such, part
of the decline in cortical postsynaptic spine density may be medi-
ated by microglia that actively participate in the phagocytosis of
cortical synapses upon pTAU aggregation. In addition, we noted
Lamp1þ lysosomal swelling in cortical microglia of PS mice at
6 months (Fig. 6C).
Microglial-mediated sculpting of neuronal circuits is critical for
synaptic refinement and plasticity during development, but also
plays a role in the pathogenesis of AD (Hong et al., 2016a,b;
Rajendran and Paolicelli, 2018). Different mediators, such as those
of the complement system, control this synaptic removal (Bialas
and Stevens, 2013; Schafer et al., 2012; Stephan et al., 2012;
Stevens et al., 2007). Interestingly, genes related to complement
activation are differentially expressed in the CNS of young tauop-
athy mice and complement itself has been found to localize to
neuronal pTAU (Ke et al., 2019). Together with our findings, these
reports underline microglia to be actively involved in spine elimi-
nation and suggest that microglia actively reshape synapses in a
tauopathy-induced neurodegenerative environment.
In conclusion, our results illustrate microglia to actively respond
to neuronal pTAU aggregation in the early stages of tau processing.
This microglial response included retraction of ramifications,
swelling of lysosomes and the loss of homeostatic microglia
markers such as P2Y12 and Tmem119. The increased lysosomal
volumes of microglia were accompanied by lysosomal localization
of both pTAU and postsynaptic structures. Interestingly, this pTAU-
inducedmicroglial phenotype coincided with an overall decrease in
cortical postsynaptic density in PS mice. Altogether, our findings
provide new insights suggesting microglia to actively respond to
neuronal pTAU aggregation and give a timeframe for which tau-
opathy stage should be modulated to regulate microglial-mediated
clearance of neuronal pTAU and cortical spines.
3. Materials and methods
3.1. Animals, tissue processing, and immunohistochemistry
Nontransgenic CBAxC57BL6 mice and homozygous Thy1-
hTAU.P301S mice (Allen et al., 2002) in a CBAxC57BL6 back-
ground were maintained at the reMYND NV center (Leuven,
Belgium). reMYND's accreditation number is LA1210532 and the
number of the protocol approved by the Ethical Committee is
161103.R01. Mice were kept in cages with 12-hour light/dark cycles
and food and water was available ad libitum. For the different ex-
periments, groups of mice (n  5 per group) were sacrificed at 2, 3,
4, 4.5, 5, 5.5, and 6 months of age. To do so, mice were anesthetized
with ketamine, xylazin 2%, atropine, and saline (4:2.5:1:2.5). Tem-
perature was monitored with a rectal thermometer and body
temperature was maintained accordingly using a heating blanket.
Once the body cavity was opened, the left ventricle was punctured
for transcardial perfusion with a peristaltic pump and ice-cold sa-
line for 3 minutes (3 mL/min). Simultaneously, the right atriumwas
cut to allow excess of liquid to escape. Next, the head was removed
from the body and the brains were isolated from the skull. From
here on, all tissues were randomized and samples were blinded.
From every brain, the left hemisphere was postfixed with 4%
paraformaldehyde in PBS and processed for western blotting as
described in the respective section. The right hemisphere was
postfixed overnight (4% PFA in PBS, 4 C) and stored in PBS with
0.1% (v/w) sodium azide (4 C) before sectioning. More specifically,per mouse, 40-mm thick sections at intervals of 160 mm were
collected using a vibratome (VT1200, Leica) and stored in PBS at 4
C for immunohistochemical analysis. For immunohistochemistry,
the following primary (Table 1) and secondary (Table 2) antibodies
were used. All sections were counterstained for DNA using DAPI
(Invitrogen. 1:10,000).3.2. Microscopy and morphological analysis
Immunostained brain sections were imaged using either a Zeiss
imager D2 fluorescent microscope, a Nikon A1R confocal micro-
scope or a Leica TCS SP8 HyD confocal microscope. For pTAU
coverage, the thresholded AT8 and PHF6 signals were measured in
the cortex and in the pyramidal cell layer of the hippocampal
cornus ammonum and granule cell layer of the hippocampal den-
tate gyrus, using ImageJ and expressed as a relative surface area
percentage of the total surface. Iba1þ cells were traced and
analyzed using the Sholl Analysis Plugin (Ferreira et al., 2014) per
animal as previously described (van Olst et al., 2018). All cells were
traced manually by going through the z-stack/dimension and
resulting 2D images were used as input to perform the aforemen-
tioned (standard Fiji-) Sholl analysis. Per animal, 6e14 cells were
selected for tracing. Cells were randomly selected, but had to meet
several inclusion criteria: 1) cells should be completely included
within the z-stack borders of the image, 2) cells should not overlap
with one another, and 3) cells should reside in the 2nd-3rd cortical
layer. The area occupied by microglia was measured using Fiji
software and determined from the Iba1þ area divided over the total
surface area.
The expression of homeostatic markers Tmem119 and P2Y12
was measured within the thresholded Iba1þ mask to obtain fluo-
rescence intensity solely from Iba1þ microglia. Fluorescence in-
tensity was normalized to the intensity of Iba1.
For CD68 analysis, 2 sections per animal were analyzed. The
Imaris 64 software (version 9.1.2, Bitplane AG) was used to
quantify microglial (Iba1þ) and lysosomal/endosomal (CD68þ)
signals (e.g., number of objects, volume per identified object and
total volume of all identified objects) in the individual corre-
sponding channels. The lysosomal signal was masked by the
microglial signal to obtain lysosomal information solely from ly-
sosomes present inside Iba1þ microglia. The total volume of the
microglial/lysosomal signal was then normalized by the volume of
the imaged section (212.81 mm * 212.81 mm * 5 mm * number of z-
stacks). Relative lysosomal volume (%) was calculated by dividing
the total lysosomal volume by the total microglial volume per im-
age. Per animal, all values were averaged from the individual im-
ages. Next, the identified lysosomes were used as a mask to search
for AT8þ signals inside microglial lysosomes. The relative AT8
volumes (%) were calculated by dividing total AT8 volume by the
Table 2
Secondary antibodies used
Antigen Label Species Dilution Manufacturer Cat. Number
Mouse Alexa488 Goat 1:500 Invitrogen A28175
Rabbit Alexa555 Goat 1:400 Invitrogen A27039
Rat Alexa647 Goat 1:500 Invitrogen A21247
Goat Alexa647 Donkey 1:400 Invitrogen A21447
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were averaged from 2 analyzed images.
For postsynaptic density analysis and synaptic engulfment by
Iba1þ cells,10e20 z-stacks weremade per section per animal in the
3rd cortical layer. Each z-stack was focused to image a single Iba1þ
cell with 2.5 zoom function using a 100 objectivewith a step size
of 0.3 mm on a Leica TCS SP8 HyD confocal microscope. First, the
Imaris x64 software (version 9.1.2, Bitplane AG) was used to make
volumes of nuclei (DAPI), microglia (Iba1), lysosomes (Lamp1) and
spots of postsynaptic terminals (Homer1) on 20 selected z-slices
from the z-stack. To measure postsynaptic density, the Homer1þ
spots were created with a spot diameter of 0.5 mm and a quality
filter threshold of 1450. Unspecific Homer1þ reactivity in the cell
nuclei was excluded by filtering out double positive DAPIþ Hom-
er1þ spots. The final density of Homer1þ particles was calculated
by dividing the number of spots by the total volume of the imaged
section ((x * y * 0.3 mm * 20 z-slices)eDAPI volume). Per animal, all
values were averaged from 10e20 analyzed images.
For engulfment of Homer1þ spines by Iba1þ cells, Kiss and Run
XT analysis was performed in batch to create a new channel that
displayed the distance between each Homer1þ spot and the Iba1þ
and Lamp1þ volumes. Because Lamp1 is a general lysosomal
marker that is not specific tomicroglia, created Lamp1 volumes that
were negative for Iba1 expression were excluded. Iba1þ Homer1þ
spots in direct contact with microglia processes and completely
internalized Lamp1þ Iba1þ Homer1þ spots were selected and
analyzed using the newly created distance-transformed channel by
setting the distance-threshold between each spot and surface of
interest to 0 mm. Finally, the interaction of microglia with Homer1þ
synaptic terminals was calculated by dividing the number of con-
tacted/internalized Iba1þ Homer1þ spots and the number of
totally engulfed Lamp1þ Iba1þ Homer1þ spots by the total volume
of the imaged section ((x * y * 0.3 mm * 20 z-slices) e DAPI volume).
Relative lysosomal volume of Lamp1 (%) was calculated by dividing
the total Lamp1þ volume by the total Iba1þ volume per image.
Again, per animal, all values were averaged from 10e20 analyzed
images.
3.3. Homogenization and differential extraction for western blot
analyses
Differential extraction was performed after homogenizing the
cortex with a potter-type mechanical homogenizer (VOS 14 S40,
rate: 750 rpm; VWR) in 9 weight-volumes of ice-cold homogeni-
zation buffer, containing 20 mM Tris-HCl (pH 7.6), 150 mM NaCl,
1 mM ethylene diamine tetra acetic acid (EDTA, Merck), 1 mM
ethylene glycol tetra acetic acid (EGTA, Sigma-Aldrich), 10 mM 1,10-
ortho-phenanthroline monohydrate (Sigma-Aldrich), a cocktail of
proteinase inhibitors (Complete, Roche, Germany), halt protease
and phosphatase inhibitor (at a 2 concentration, Thermo Fisher
Scientific, Belgium) and deacetylase inhibitors Trichostatin (1 mM,
Sigma-Aldrich) and nicotinamide (5 mM, Sigma-Aldrich). A fixed
volume of approximately half of the total homogenates (TotH) was
centrifuged (136000  g, 60 minutes, 4 C; TLA-55 rotor, Optima
TLX Ultracentrifuge, Beckman Coulter) to generate a Tris-soluble
fraction (SF), whereas the remainder was stored at 80 C. Thesupernatant (S1, further referred to as soluble fraction or SF) was
separated from the pellet (P1), and stored at 80 C. The pellet (P1)
was solubilized in 9 weight-volumes high-salt (0.85 M NaCl) con-
taining homogenization buffer. This fraction was centrifuged
(20000 g, 30 minutes, 4 C) and the resulting high-salt pellet (P2)
was stored at 80 C. The supernatant (S2) was brought to 1%
Sarkosyl with 10% Sarkosyl and incubated at room temperature for
60 minutes in a ThermoMixer (at room temperature) and then
centrifuged (136000  g, 60 minutes, 4 C). The supernatant (S3,
further referred to as Sarkosyl-soluble fraction or SSF) was stored
at 80 C. The pellet (P3) was resuspended in homogenization
buffer (2 mL per mg tissue) and stored at 80 C (further referred to
as insoluble fraction or IF).
3.4. Polyacrylamide gel electrophoreses and western blotting
For application of conventional SDS-PAGE and western blotting,
samples were denatured and reduced by incubation at 95 C for
10 minutes after addition of SDS-PAGE sample buffer (XT sample
buffer (4) or Laemmli buffer, Bio-Rad; final concentration of 1
sample buffer with 2.5% (v/v) 2-mercaptoethanol). The samples
were separated on either 7.5% Tris-HCl gels or 4%e12% Bis-Tris gels
(Criterion XT Precast Gel, 26-well comb, 10 mL, 1.0 mm; Bio-Rad).
After dry electro transfer (Trans-Blot Turbo Transfer System, Bio-
Rad) to PVDF membranes (Trans-Blot Turbo Midi PVDF Transfer,
Bio-Rad), the membranes were washed in Tris-buffered saline.
Next, the membranes were incubated in Tris-buffered saline
(pH 7.6) with 0.1% (v/v) Tween-20 containing 5% (w/v) nonfat dry
milk for 1 hour at room temperature. Blots were incubated with the
primary antibody overnight (1:500, AT8 Thermo Fisher Scientific,
MN1020). After washing and incubation with an HRP-conjugated
secondary antibody (goat-anti-mouse IgG, DAKO) blots were
developed by the ECL detection system (LiteAblotR Plus ECL sub-
strate, EuroClone; or SuperSignal West FemtoMaximum Sensitivity
Substrate, Thermo Fisher Scientific) and images were recorded
digitally (VisionWorks Acquisition, UVP) with different exposure
times. Dedicated software (VisionWorks Analysis, UVP) was used
for analysis of the blots.
All TotH and SF blots were reprobed with anti-NSE (Abcam
Ab16807; dilution 1:1000) as loading control. Samples were run in
duplicate. For IF no suitable loading control is known. As multiple
gels will be used for each antibody, reference samples of either TotH
or SF fractions were run on each gel as an intergel reference. For the
IF fractions, TotH reference material also was used on each gel.
3.5. Statistical analysis
All data reflect mean  SEM and all comparisons were statisti-
cally tested in GraphPad Prism 8.2.1, using either unpaired two-
tailed Student's t-tests for comparing 2 experimental groups, or
two-way analysis of variance test when more than 2 groups were
compared. With these statistical tests, significant differences are
indicated and reflect the following p-values: *p < 0.05, **p < 0.01,
and ***p < 0.001. Sholl analysis curves from which area under the
curve data were deduced, were created, and analyzed using
GraphPad Prism 8.2.1.
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